{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:04:42Z","timestamp":1791421482841,"version":"4.3.3"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Topical steroid withdrawal syndrome (TSW) is an adverse event following discontinuation of topical corticosteroids (TCS) and is of growing interest among patients and dermatologists. The absence of well-defined diagnostic criteria and limited insights into the pathomechanisms make diagnosis and future research challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To propose preliminary diagnostic criteria for TSW with the erythemato-oedematous subtype applicable for adult and paediatric populations using a Delphi consensus approach informed by a thorough literature review that summarizes the signs, symptoms and histology of TSW.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eleven clinicians experienced in diagnosing and treating suspected TSW in both children and adults participated in a three-round modified Delphi process. Two rounds of surveys were conducted, with items ranked using a 5-point Likert scale. A predefined consensus threshold of \u2265 75% was established for any one feature to be deemed important. The third round involved a live video conference where the panel reached a consensus on essential diagnostic criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The panel identified 18 critical diagnostic items, encompassing elements from the patient\u2019s clinical history, signs and symptoms. This includes history of escalating TCS requirement, morphology and distribution differing from primary condition, regional or generalized spontaneous neuropathic pain and severe burning sensation of the skin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Differentiating TSW from conditions such as severe atopic dermatitis remains challenging. By emphasizing the common signs and symptoms of TSW, we aim to encourage discussions among healthcare professionals and progress towards the development of a reliable diagnostic tool.<\/jats:p>\n                    <jats:p>An author video to accompany this article is available online.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf518","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:04:25Z","timestamp":1765458265000},"page":"768-778","source":"Crossref","is-referenced-by-count":5,"title":["Topical steroid withdrawal syndrome: developing diagnostic criteria through a modified Delphi method"],"prefix":"10.1093","volume":"194","author":[{"given":"Cynhia","family":"Hsu","sequence":"first","affiliation":[{"name":"Chicago Medical School, Rosalind Franklin University of Medicine and Science , Chicago, IL ,","place":["USA"]},{"name":"Advocate Christ Medical Center, Internal Medicine , Oak Lawn, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Guo","sequence":"additional","affiliation":[{"name":"Chicago Medical School, Rosalind Franklin University of Medicine and Science , Chicago, IL ,","place":["USA"]},{"name":"Department of Dermatology, Brown University , Providence, RI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Adams","sequence":"additional","affiliation":[{"name":"Twelve Bridges Dermatology , Lincoln, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Davis","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Eichenfield","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, University of California, San Diego and Rady Children\u2019s Hospital-San Diego , San Diego, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Hsu\u00a0Friedman","sequence":"additional","affiliation":[{"name":"Amethyst Holistic Skin Solutions , Naperville, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Harris","sequence":"additional","affiliation":[{"name":"Patient Advocate , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Serrao","sequence":"additional","affiliation":[{"name":"Dermatologists of Southwest Ohio , Mason, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Sheary","sequence":"additional","affiliation":[{"name":"Royal Randwick Medical Centre , Randwick, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Washington , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sidbury","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington School of Medicine , Seattle, WA ,","place":["USA"]},{"name":"Department of Dermatology, Seattle Children\u2019s Hospital , Seattle, WA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Simpson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Oregon Health and Science University , Portland, OR ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaDe","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lio","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"2026031913340742300_ljaf518-B1","author":"International Topical Steroid Awareness Network"},{"key":"2026031913340742300_ljaf518-B2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anai.2022.09.031","article-title":"Corticosteroid exposure and cumulative effects in patients with eczema: Results from a patient survey","volume":"130","author":"Barta","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026031913340742300_ljaf518-B3","author":"National Eczema Society"},{"key":"2026031913340742300_ljaf518-B4","doi-asserted-by":"crossref","first-page":"e060867","DOI":"10.1136\/bmjopen-2022-060867","article-title":"Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients","volume":"12","author":"Tan","year":"2022","journal-title":"BMJ Open"},{"key":"2026031913340742300_ljaf518-B5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/bjd\/ljac067","article-title":"Topical corticosteroid withdrawal syndrome: the patient community call for high-quality research, clear definitions and diagnostic criteria","volume":"188","author":"Howells","year":"2023","journal-title":"Br J Dermatol"},{"key":"2026031913340742300_ljaf518-B6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.anai.2023.12.022","article-title":"Topical steroid withdrawal and atopic dermatitis","volume":"132","author":"Marshall","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026031913340742300_ljaf518-B7","doi-asserted-by":"crossref","first-page":"adv44209","DOI":"10.2340\/actadv.v105.44209","article-title":"Topical steroid withdrawal: perspectives of Dutch healthcare professionals","volume":"105","author":"Vroman","year":"2025","journal-title":"Acta Derm Venereol"},{"key":"2026031913340742300_ljaf518-B8","doi-asserted-by":"crossref","first-page":"e57687","DOI":"10.2196\/57687","article-title":"Reviewing the evidence base for topical steroid withdrawal syndrome in the research literature and social media platforms: an evidence gap map","volume":"26","author":"Orr","year":"2024","journal-title":"J Med Internet Res"},{"key":"2026031913340742300_ljaf518-B9","doi-asserted-by":"crossref","first-page":"1547923","DOI":"10.3389\/falgy.2025.1547923","article-title":"Breaking the cycle: a comprehensive exploration of topical steroid addiction and withdrawal","volume":"6","author":"Maskey","year":"2025","journal-title":"Front Allergy"},{"key":"2026031913340742300_ljaf518-B10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/ced\/llad161","article-title":"Topical steroid withdrawal: an emerging clinical problem","volume":"48","author":"Brookes","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"2026031913340742300_ljaf518-B11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/ced\/llaf087","article-title":"Topical steroid withdrawal response to ciclosporin","volume":"50","author":"McSwiney","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"2026031913340742300_ljaf518-B12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jdcr.2024.03.011","article-title":"Topical steroid withdrawal treated with ruxolitinib cream","volume":"48","author":"Shea","year":"2024","journal-title":"JAAD Case Rep"},{"key":"2026031913340742300_ljaf518-B13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J Methodol"},{"key":"2026031913340742300_ljaf518-B14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2014.11.024","article-title":"A systematic review of topical corticosteroid withdrawal (\u201csteroid addiction\u201d) in patients with atopic dermatitis and other dermatoses","volume":"72","author":"Hajar","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2026031913340742300_ljaf518-B15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1080\/09546634.2021.1882659","article-title":"Topical corticosteroid withdrawal (\u2018steroid addiction\u2019): an update of a systematic review","volume":"33","author":"Hwang","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2026031913340742300_ljaf518-B16","first-page":"386","article-title":"Topical corticosteroid addiction and withdrawal - an overview for GPs","volume":"45","author":"Sheary","year":"2016","journal-title":"Aust Fam Physician"},{"key":"2026031913340742300_ljaf518-B17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ced\/llae045","article-title":"Topical steroid withdrawal: a survey of UK dermatologists\u2019 attitudes","volume":"49","author":"Barlow","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"2026031913340742300_ljaf518-B18","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archderm.140.8.1013","article-title":"Serum nitric oxide levels in \u201cred\u201d patients: separating corticosteroid-addicted patients from those with chronic eczema","volume":"140","author":"Rapaport","year":"2004","journal-title":"Arch Dermatol"},{"key":"2026031913340742300_ljaf518-B19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.dsi.2015.05.002","article-title":"Barrier abnormalities and keratinocyte-derived cytokine cascade after cessation of long-term topical glucocorticosteroid on hairless mouse skin","volume":"33","author":"Lin","year":"2015","journal-title":"Dermatol Sin"},{"key":"2026031913340742300_ljaf518-B20","doi-asserted-by":"crossref","first-page":"18954","DOI":"10.5070\/D3197018954","article-title":"Tachyphylaxis to topical glucocorticoids; what is the evidence?","volume":"19","author":"Taheri","year":"2013","journal-title":"Dermatol Online J"},{"key":"2026031913340742300_ljaf518-B21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000489125","article-title":"Evaluation of hypothalamic-pituitary-adrenal axis suppression following cutaneous use of topical corticosteroids in children: a meta-analysis","volume":"89","author":"Wood Heickman","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"2026031913340742300_ljaf518-B22","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.4103\/jfmpc.jfmpc_1330_23","article-title":"Hypothalamus-pituitary-adrenal axis (HPA axis) suppression with inappropriate use of steroids in recalcitrant dermatophytosis: a cross-sectional study","volume":"13","author":"Kaur","year":"2024","journal-title":"J Family Med Prim Care"},{"key":"2026031913340742300_ljaf518-B23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s13256-022-03659-2","article-title":"Topical glucocorticoid application causing iatrogenic Cushing\u2019s syndrome followed by secondary adrenal insufficiency in infants: two case reports","volume":"16","author":"Matejek","year":"2022","journal-title":"J Med Case Rep"},{"key":"2026031913340742300_ljaf518-B24","first-page":"202","article-title":"Adrenal insufficiency and diabetes mellitus secondary to the use of topical corticosteroids for cosmetic purpose","volume":"64","author":"Sobngwi","year":"2003","journal-title":"Ann Endocrinol (Paris)"},{"key":"2026031913340742300_ljaf518-B25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00128071-200203030-00001","article-title":"Topical corticosteroid-induced adrenocortical insufficiency","volume":"3","author":"Levin","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"2026031913340742300_ljaf518-B26","author":"Lio"},{"key":"2026031913340742300_ljaf518-B27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/DER.0000000000000387","article-title":"Steroid withdrawal effects following long-term topical corticosteroid use","volume":"29","author":"Sheary","year":"2018","journal-title":"Dermatitis"},{"key":"2026031913340742300_ljaf518-B28","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jid.2024.11.026","article-title":"Topical steroid withdrawal is a targetable excess of mitochondrial NAD","volume":"145","author":"Shobnam","year":"2025","journal-title":"J Invest Dermatol"},{"key":"2026031913340742300_ljaf518-B29","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic dermatitis","volume":"384","author":"St\u00e4nder Sonja","year":"2021","journal-title":"N Engl J Med"},{"key":"2026031913340742300_ljaf518-B30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaip.2019.06.044","article-title":"Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection","volume":"8","author":"Fishbein","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026031913340742300_ljaf518-B31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2026031913340742300_ljaf518-B32","author":"Lio"},{"key":"2026031913340742300_ljaf518-B33","doi-asserted-by":"crossref","first-page":"491376","DOI":"10.1155\/2013\/491376","article-title":"Steroid dermatitis resembling rosacea: a clinical evaluation of 75 patients","volume":"2013","author":"Hameed","year":"2013","journal-title":"ISRN Dermatol"},{"key":"2026031913340742300_ljaf518-B34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/1523-1747.ep12260665","article-title":"Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin","volume":"82","author":"Zheng","year":"1984","journal-title":"J Invest Dermatol"},{"key":"2026031913340742300_ljaf518-B35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0738-081X(02)00365-6","article-title":"Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome","volume":"21","author":"Rapaport","year":"2003","journal-title":"Clin Dermatol"},{"key":"2026031913340742300_ljaf518-B36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0019-5154.77547","article-title":"Steroid-induced rosacea: a clinical study of 200 patients","volume":"56","author":"Bhat","year":"2011","journal-title":"Indian J Dermatol"},{"key":"2026031913340742300_ljaf518-B37","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.jaad.2016.05.048","article-title":"The role of delayed-delayed corticosteroid contact dermatitis in topical steroid withdrawal","volume":"75","author":"Gust","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2026031913340742300_ljaf518-B38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2133.1979.tb05616.x","article-title":"Perioral dermatitis: a 12-year review","volume":"101","author":"Wilkinson","year":"1979","journal-title":"Br J Dermatol"},{"key":"2026031913340742300_ljaf518-B39","first-page":"19","article-title":"Diagnosis and management of the red face syndrome","volume":"1","author":"Uehara","year":"1996","journal-title":"Dermatol Ther"},{"key":"2026031913340742300_ljaf518-B40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0190-9622(99)70118-0","article-title":"Eyelid dermatitis to red face syndrome to cure: clinical experience in 100 cases","volume":"41","author":"Rapaport","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"2026031913340742300_ljaf518-B41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.1524-4725.1999.99097.x","article-title":"Prolonged erythema after facial laser resurfacing or phenol peel secondary to corticosteroid addiction","volume":"25","author":"Rapaport","year":"1999","journal-title":"Dermatol Surg"},{"key":"2026031913340742300_ljaf518-B42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1071\/SH13052","article-title":"Red scrotum syndrome: idiopathic neurovascular phenomenon or steroid addiction?","volume":"10","author":"Narang","year":"2013","journal-title":"Sex Health"},{"key":"2026031913340742300_ljaf518-B43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4183\/aeb.2016.232","article-title":"Topical steroid induced facial rosaceiform dermatitis","volume":"12","author":"Tatu","year":"2016","journal-title":"Acta Endocrinol (Buchar)"},{"key":"2026031913340742300_ljaf518-B44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3315\/jdcr.2016.1222","article-title":"A clinical and etiological study of 103 patients","volume":"10","author":"C\u00e9sar","year":"2016","journal-title":"J Dermatol Case Rep"},{"key":"2026031913340742300_ljaf518-B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0019-5154.48976","article-title":"Erythroderma: review of a potentially life -threatening dermatosis","volume":"54","author":"Okoduwa","year":"2009","journal-title":"Indian J Dermatol"},{"key":"2026031913340742300_ljaf518-B46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"2026031913340742300_ljaf518-B47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026031913340742300_ljaf518-B48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/archderm.1973.01620270014003","article-title":"A clinicopathologic study of 135 cases","volume":"108","author":"Nicolis","year":"1973","journal-title":"Arch Dermatol"},{"issue":"5 Pt 1","key":"2026031913340742300_ljaf518-B49","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0190-9622(89)70287-5","article-title":"Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients","volume":"21","author":"Boyd","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"2026031913340742300_ljaf518-B50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000246075","article-title":"Psoriatic erythroderma: a histopathologic study of forty-five patients","volume":"194","author":"Tomasini","year":"1997","journal-title":"Dermatology"},{"key":"2026031913340742300_ljaf518-B51","volume-title":"StatPearls","author":"Tucker","year":"2025"},{"key":"2026031913340742300_ljaf518-B52","first-page":"349","article-title":"Scabies cases misdiagnosed and treated as allergic diseases: Itch as alarm","volume":"61","author":"Lugovi\u0107-Mihi\u0107","year":"2022","journal-title":"Acta Clin Croat"},{"key":"2026031913340742300_ljaf518-B53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4632.2004.01959.x","article-title":"Pellagra: dermatitis, dementia, and diarrhea","volume":"43","author":"Hegyi","year":"2004","journal-title":"Int J Dermatol"},{"key":"2026031913340742300_ljaf518-B54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2006.08.015","article-title":"Acrodermatitis enteropathica and an overview of zinc metabolism","volume":"56","author":"Maverakis","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"2026031913340742300_ljaf518-B55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2500\/aap.2006.27.2853","article-title":"Atopic dermatitis or hyper-IgE syndrome?","volume":"27","author":"Ohameje","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"2026031913340742300_ljaf518-B56","author":"Lio"},{"key":"2026031913340742300_ljaf518-B57","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jid.2019.11.007","article-title":"Netherton syndrome: insights into pathogenesis and clinical implications","volume":"140","author":"Chiticariu","year":"2020","journal-title":"J Invest Dermatol"},{"key":"2026031913340742300_ljaf518-B58","first-page":"e3070","article-title":"Netherton syndrome: a case report and review of literature","volume":"10","author":"Saleem","year":"2018","journal-title":"Cureus"},{"key":"2026031913340742300_ljaf518-B59","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s004310100816","article-title":"Reviewing Omenn syndrome","volume":"160","author":"Aleman","year":"2001","journal-title":"Eur J Pediatr"},{"key":"2026031913340742300_ljaf518-B60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/pde.14401","article-title":"Diagnosing Omenn syndrome","volume":"38","author":"Cutts","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"2026031913340742300_ljaf518-B61","first-page":"e26606","article-title":"Langerhans cell histiocytosis presented as persistent diaper dermatitis: a case report","volume":"14","author":"Moscona-Nissan","year":"2022","journal-title":"Cureus"},{"key":"2026031913340742300_ljaf518-B62","volume-title":"StatPearls","author":"Tillotson","year":"2023"},{"key":"2026031913340742300_ljaf518-B63","first-page":"2809","article-title":"Cutaneous T-cell lymphoma presenting as benign dermatoses","volume":"59","author":"Elmer","year":"1999","journal-title":"Am Fam Physician"},{"key":"2026031913340742300_ljaf518-B64","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/0019-5154.152566","article-title":"Poikiloderma vasculare atrophicans: a distinct clinical entity?","volume":"60","author":"Mahajan","year":"2015","journal-title":"Indian J Dermatol"},{"key":"2026031913340742300_ljaf518-B65","first-page":"e7186","article-title":"Carcinoid syndrome: a review","volume":"12","author":"Gade","year":"2020","journal-title":"Cureus"},{"issue":"Suppl.","key":"2026031913340742300_ljaf518-B66","doi-asserted-by":"crossref","first-page":"P113","DOI":"10.1016\/j.jaad.2003.10.379","article-title":"Cutaneous manifestations of the malignant carcinoid syndrome","volume":"50","author":"Kleyn","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2026031913340742300_ljaf518-B67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000375120","article-title":"Multiple myeloma and atopic eczema in an adult","volume":"8","author":"Hossain","year":"2015","journal-title":"Case Rep Oncol"},{"key":"2026031913340742300_ljaf518-B68","first-page":"1581","article-title":"Cutaneous sarcoidosis: a dermatologic masquerader","volume":"65","author":"Katta","year":"2002","journal-title":"Am Fam Physician"},{"key":"2026031913340742300_ljaf518-B69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clindermatol.2019.01.005","article-title":"Sarcoidosis: a great imitator","volume":"37","author":"Karada\u011f","year":"2019","journal-title":"Clin Dermatol"},{"key":"2026031913340742300_ljaf518-B70","first-page":"9636","article-title":"The first reported case of erythrodermic sarcoidosis with systemic involvement during COVID-19 vaccination","volume":"15","author":"Tchernev","year":"2023","journal-title":"Dermatol Reports"},{"key":"2026031913340742300_ljaf518-B71","volume-title":"StatPearls","author":"Yee","year":"2025"},{"key":"2026031913340742300_ljaf518-B72","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.7573\/dic.2020-5-6","article-title":"Tinea corporis: an updated review","volume":"9","author":"Leung","year":"2020","journal-title":"Drugs Context"},{"key":"2026031913340742300_ljaf518-B73","first-page":"702","article-title":"Diagnosis and management of tinea infections","volume":"90","author":"Ely","year":"2014","journal-title":"Am Fam Physician"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf518\/65847155\/ljaf518.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/4\/768\/65847155\/ljaf518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/4\/768\/65847155\/ljaf518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:34:23Z","timestamp":1773941663000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/4\/768\/8377422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":73,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,11]]},"published-print":{"date-parts":[[2026,3,19]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf518","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,12,11]]}}}